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Abstract
Background: Obesity and sedentary lifestyle are major health problems and key
features to develop cardiovascular disease. Data on the effects of lifestyle
interventions in diabetics with chronic kidney disease (CKD) have been conflicting.
Study Design: Systematic review.
Population: Diabetes patients with CKD stage 3 to 5.
Search Strategy and Sources: Medline, Embase and Central were searched to
identify papers.
Intervention: Effect of a negative energy balance on hard outcomes in diabetics
with CKD.
Outcomes: Death, cardiovascular events, glycaemic control, kidney function,
metabolic parameters and body composition.
Results: We retained 11 studies. There are insufficient data to evaluate the effect
on mortality to promote negative energy balance. None of the studies reported a
difference in incidence of Major Adverse Cardiovascular Events. Reduction of
energy intake does not alter creatinine clearance but significantly reduces
proteinuria (mean difference from 20.66 to 21.77 g/24 h). Interventions with
combined exercise and diet resulted in a slower decline of eGFR (29.2 vs.
220.7 mL/min over two year observation; p,0.001). Aerobic and resistance
exercise reduced HbA1c (20.51 (20.87 to 20.14); p50.007 and 20.38 (20.72 to
20.22); p50.038, respectively). Exercise interventions improve the overall
functional status and quality of life in this subgroup. Aerobic exercise reduces BMI
(20.74% (21.29 to 20.18); p50.009) and body weight (22.2 kg (23.9 to 20.6);
p50.008). Resistance exercise reduces trunk fat mass (20,7¡0,1 vs. +0,8 kg
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¡0,1 kg; p50,00120,005). In none of the studies did the intervention cause an
increase in adverse events.
Limitations: All studies used a different intervention type and mixed patient groups.
Conclusions: There is insufficient evidence to evaluate the effect of negative
energy balance interventions on mortality in diabetic patients with advanced CKD.
Overall, these interventions have beneficial effects on glycaemic control, BMI and
body composition, functional status and quality of life, and no harmful effects were
observed.
Diabetes mellitus (DM) currently affects approximately 382 million people
Diabetes is a prominent metabolic complication of obesity, which can be viewed
as the result of a prolonged period of excess energy. Increasing energy expenditure
by physical activity and reducing energy intake by caloric restriction are therefore
mainstays of diabetes therapy to reduce cardiovascular risk and improve
glycaemic control. The approach requires specific intensive programs and follow-
up, which might have substantial impact on costs and resources. Diabetes is one of
the leading causes of end stage kidney disease (ESKD) worldwide. Approximately
1 of 3 adults with diabetes has chronic kidney disease (CKD) and this proportion
patients with CKD is complex because of the multitude of systemic complications
and often unstable clinical conditions, particularly in dialysis patients. Promoting
energy expenditure or limiting energy intake in this population might therefore be
challenging.
In diabetic patients with CKD, physical activity may have several potential
benefits, including weight loss, improved muscle strength and cardiorespiratory
fitness, reduction in blood pressure, and improved mood. Exercise during
haemodialysis may also improve dialysis efficiency but can be associated with
harms and increased risk of acute cardiovascular events. Similarly, provision of
dietary advice to restrict caloric intake could have positive effects on several
outcomes amongst patients with diabetes mellitus and CKD but could also lead
to malnutrition, particularly in dialysis patients, and could decrease quality of
life. In this systematic review we thus aimed to ascertain whether interventions
focused at increasing energy expenditure or limiting energy intake may
influence major outcomes, such as survival, cardiovascular events, kidney
function, physical performance and quality of life in diabetics with CKD or on
dialysis.
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Introduction
worldwide and its prevalence is expected to increase to 592 million by 2035 [1].
is steadily increasing in people with type 2 diabetes [2]. Management of diabetic
Methods
Data source and search strategy
MEDLINE, EMBASE and CENTRAL databases were searched for English-
language articles without time restriction, through focused, high sensitive search
strategies (Table S1). References from relevant studies and reviews published on
the same topic were screened for supplementary articles.
Study selection
We included all randomized or non-randomized trials, and single-arm,
prospective or retrospective observational studies providing longitudinal data on
the effect of energy expenditure on diabetic patients with clinically overt CKD,
including ESKD on chronic renal replacement therapy. Studies were considered
without restrictions on duration of follow-up. We planned to analyse studies
dealing with diabetes (type 1 or 2) either as a cause of CKD or as a superimposed
condition. Studies where a well-defined part of the population fulfilled the above
criteria were included in the review. Interventions targeting energy control
included lifestyle modifications, exercise, diet or multidisciplinary programs
including two or more of these interventions. Outcomes of interest included all
cause and cardiovascular mortality, major adverse cardiovascular events (MACE),
glycaemic and blood pressure control, renal function (GFR, creatinine,
proteinuria), body composition and weight, functional status, hospital admissions
and quality of life. Studies were excluded if: 1) they did not include diabetic
patients with CKD or CKD patients without diabetes; 2) they did not provide
longitudinal data on the above mentioned outcomes after the planned
intervention; 3) they examined (an) intervention(s) related to fluid (rather than
energy) control. Case reports, reviews, editorials, letters and studies performed on
children (age ,18) or animals were excluded as well, although screened as
potential sources of additional references. Relevant studies were selected by three
authors (DB, CT and LVH). Data extraction was independently performed in
duplicate by two authors (DB and LVH).
Quality assessment
We used the Newcastle-Ottawa Scale to assess the study quality of observational
studies. This scale considers a quality score calculated on the basis of three major
items: Study participants (0 to 4 points), adjustment for confounding (0 to 2
points) or ascertainment of the exposure or outcome of interest (0 to 3 points)
with a maximum score of 9 points which represents the highest methodological
quality. The quality of RCTs was assessed using the checklist developed by the
Cochrane Renal Group which evaluated the presence of potential selection bias
(random sequence generation and allocation concealment), performance bias
(blinding of investigators and participants), detection bias (blinding of outcome
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assessors), attrition bias (incomplete outcome data) and reporting bias (selective
reporting).
Data extraction and analysis
Data extraction and analysis were performed in duplicate by two reviewers
independently (DB and LVH) and verified by a third one (CT). In studies
considering mixed populations, the subgroup of patients with documented CKD
and diabetes was selectively described only if corresponding data were available.
Results
Search results
The flow diagram of the selection process is depicted in Figure 1. One thousand-
eighteen potentially relevant references were initially found. A total of nine
hundred and fifty five citations were excluded because of search overlap, because
they dealt with population without the inclusion criteria or because they did not
contain original research. Case reports were also excluded as the information was
regarded as too fragmentary. Two articles were added by additional sources.
Amongst sixty-five studies selected for full text examination, fifty-four studies
were excluded because: they dealt with interventions not affecting energy balance
(n513); they did not provide longitudinal outcome data (n58); or because
diabetes or CKD was not explicitly reported to be present in the study population
(n533). A total of eleven studies was therefore reviewed in detail and included in
the review. The main characteristics of these studies are summarized in Table 1.
Study characteristics
Types of studies, populations and interventions.
patients had proteinuria and a serum creatinine level below 2 mg/dL. In Matsuoka
above 2.26 mg/dL but gave no additional information on kidney function. Two
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Six studies were randomized controlled trials [3,4,5,6,7,8], one was a non-
randomized controlled trial [9], three were prospective uncontrolled studies
[10,11,12] and one was a retrospective study [13]. The number of participants
included in each study ranged from 4 [10] to 251 [6].
The severity of renal function impairment was variable. MacLaughlin [9]
included patients with CKD stage 3 to 5. Chen [4] included only CKD patients
with eGFR.15 mL/min/1.73 m2. Leehey [5] included patients with eGFR
between 15 and 90 mL/min/1,73 m2 and persistent proteinuria. In Morales [8] all
[13] and Castaneda [3] all participants had CKD but the severity was not
specified. The study of Sigal [6] excluded participants with a serum creatinine
studies [7,10] focused on hemodialysis patients. Solerte [11] included patients
with an eGFR between 66 and 13 mL/min; Saiki [12] included participants with
an eGFR between 40 and 17 mL/min, with proteinuria. The prevalence, type and
duration of diabetes, as well as glycaemic control, differed between studies. Leehey
6 months of duration, mean HbA1c was between 6.6 and 9.9% but none of the
all the participants had diabetes with no further specification of the type or
with no further information on treatment regimens or severity. Fifty percent of
dependent. The mean HbA1c was 6.88%¡1.2%. Thirty-two and forty-one
respectively, were diabetics of either type. All studies excluded participants with
any unstable clinical condition such as heart disease, cancer or rapidly progressive
energy balance. Three studies examined the effects of a dietary intervention
Figure 1. Flow of the study selection process.
doi:10.1371/journal.pone.0113667.g001
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[5] included obese participants with type 2 diabetes and a BMI above 30 kg/m2.
Castaneda [3] selected type-2 diabetics with a disease history of at least 3 years and
a mean HbA1c of 8.6%. Patients studied by Sigal [6] had type 2 diabetes of at least
participants were treated with insulin. All patients of Solerte [11] were obese type
1 or 2 diabetics, mean HbA1c was not specified. In Saiki [12] all patients had
diabetes type 1 or 2 with a mean HbA1c of 7.11%. In the study of Matsuoka [13]
severity. In Tawney [7] 44% of the study population had diabetes and 29% were
treated with insulin. In the study of Morales [8] 46% had diabetes of any type,
the study population of Cappy [10] consisted of diabetics and 63% was insulin-
percent of the participants in the study of Maclaughlin [9] and Chen [4],
kidney disease. Five studies [3,5,6,10,13] involved physical exercise to improve
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participants got a combined dietary and aerobic exercise programme, in
counselling.
Study quality
used, with allocation concealment before randomization and block sizes varied
intervention or control group with a frequency matching strategy based on age
group (18 to 44, 45 to 64, and 65 years or older), sex, diabetes as cause of ESRD,
and ethnicity. Data on random sequence generation and allocation concealment
were not provided in any of the other RCTs included. Attrition bias was low in all
blinding of the research coordinator, the personal trainer rather than the research
coordinator handled the randomization visit. Performance and detection bias
were high in the remaining RCTs which were all not blinded. Reporting bias was
low in all studies as all the outcomes defined were reported. The general quality of
observational studies was low to moderate.
Outcomes
Mortality.
None of the studies reviewed included patient survival as a study outcome. In the
rehabilitation program vs. one in the control group but no details were available
on whether these deaths were related to the intervention.
MACEs.
None of the studies reviewed were specifically designed to evaluate MACEs as a
exercise group had a minor episode of angina pectoris, of which one was
diagnosed with angina pectoris without need for hospitalisation.
Kidney function.
Morales (8) reported no changes in mean serum creatinine or creatinine clearance
after a dietary intervention with energy intake reduction of 500 kcal per day and
lower decline in the eGFR was observed in the intervention- (weight management
program by diet, aerobic exercise and behaviour therapy) than in the usual
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[8,11,12], which consisted respectively of an energy reduction of 500 kcal per day
and protein content adjusted to 1 to 1.2 g/kg/day [8], reduction of energy intake
to 1410 kcal/day [11] and reduction to 11–19 kcal/kg/day [12]. In one study the
combination with behavioural therapy and a pharmacological intervention [9]. In
two other studies [4,7] the intervention consisted of exercise advice and
The study quality of RCTs was variable. In Sigal [6], central randomization was
randomly between 4 and 8. In Tawney [7] patients were randomized to the
studies with the exception of Tawney [7] where the overall drop-out rate was 17%
although results were reported on a per protocol basis. In Sigal [6], to permit
study of Tawney [7], three deaths occurred in the group receiving the physical
study outcome. In the paper of Castaneda [3], three patients in the resistance
hospitalised. One subject in the aerobic exercise group in the study of Sigal [6] was
limited protein intake. In a sub-population of MacLaughlin [9], a significantly
significant increase in eGFR after one year of dietary regimen (D15 mL/min;
p50.01). This can be explained by loss of muscle mass or reduced intake of
proteins since the value is an estimated GFR based on serum creatinine.
Furthermore, 9 of 26 (35%) from the weight-management program group vs. 1 of
18 (6%) from the usual-care group who were otherwise eligible were accepted for
kidney transplant listing. There were 3 transplants in the weight management
program group (2 live related donor kidney transplants, 1 cadaveric donor kidney
transplant) and 1 transplant in the usual-care group (live related donor kidney
transplant). Conversely, no significant changes in eGFR were reported by Leehey
progression to dialysis. Aerobic exercise regimens during and between
hemodialysis sessions had no effect on serum creatinine levels or dialysis dose
end of the study in subjects undergoing a diet program as compared with the
control group (1.9 g/24 h vs. 3.5 g/24 h; p,0.05). The dietary intervention in
intervention compared with baseline (respectively 20.66 g/24 h; p50.01 and
21.77 g/24 h; p,0.0001). Conversely, no significant changes in this parameter
Glycaemic control.
As compared with no exercise, resistance exercise significantly reduced mean
HbA1c (7.6¡0.2% vs. 8.3¡0.5%; p50.01) and mean fasting blood glucose levels
aerobic and resistance exercise training (20.51 (20.87 to 20.14); p50.007 and
20.38 (20.72 to20.22); p50.038, respectively). Of note, this reduction was more
pronounced when the aerobic and resistance training were combined (20.46
(20.83 to 20.09); p50.014 compared with aerobic exercise and 20.59 (20.95 to
20.23); p50.01 compared with resistance exercise alone). Two small studies
showed that low intensity aerobic exercise did not influence the mean blood
alone without supervision or control of the exercise did not alter mean blood
significantly reduced mean HbA1c compared to baseline value (6.68¡1.21 vs.
7.11¡1.42; p,0.05).
Functional status.
significantly improved after a resistance exercise intervention (p50.001). In
undergoing aerobic exercise with respect to the control group, although this
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care-group (29.2 vs. 220.7 mL/min; p,0.001). Saiki [12] showed no change in
creatinine clearance after the dietary intervention, Solerte [11] showed a
[5] after an aerobic exercise intervention. In the retrospective cohort study of
Matsuoka [13], maintenance of a physical active daily life did not affect
required [10]. In Morales [8], 24-hour proteinuria was significantly reduced at the
Solerte [11] and Saiki [12] also signficantly reduced proteinuria after the
were noticed after exercise or counselling interventions [5,13].
[3]. One large RCT [6] demonstrated a significant reduction in HbA1c with
glucose [10] or mean HbA1c [5]. Another larger study found that exercise advice
glucose levels [4].
A dietary intervention with very restricted calory intake of 4 weeks [12]
In Castaneda [3], the overall functional status as measured by a questionnaire,
Leehey [5], the mean exercise duration was more increased in the group
difference did not attain statistical significance. Studies exploring the effects of
(evaluated by a physical functioning score questionnaire) only after adjusting for
matching variables and adequacy of dialysis (p50.04).
Quality of Life.
In dialysis patients, exercise advice alone did not affect depression symptoms
retrospective cohort study, aerobic exercise significantly improved the overall
quality of life (p,0.05; Karnofsky score for fitness in daily physical activity) in
Changes in body composition/weight.
A large RCT testing a resistance exercise program demonstrated a significant
reduction in trunk fat mass (20,7¡0,1 vs. +0,8¡0,1 kg; p50.01–0,005) but not
changes in body weight, body mass index (BMI), waist circumference and fat mass
when aerobic exercise was compared to no exercise. The mean BMI in the aerobic
exercise group reduced by 0.74% (21.29 to 20.18; p50.009) while the mean
body weight was decreased by 2.2 kg (23.9 to 20.6; p50.008). These changes
were no longer significant in the resistance exercise group, but there was a trend
for lower BMI when resistance was combined with aerobic exercise when
compared with resistance exercise alone. In a small trial including only 11
participants, aerobic exercise did not result in significant changes in the mean
500 kcal and limited protein intake significantly reduced mean body weight and
significantly decreased BMI compared to baseline value (respectively 27,3 kg/m2;
p,0.001 and 22.2 kg/m2; p,0.0001). Similar observations were reported after a
combined intervention of an anti-obesity drug and individual diet and exercise
Blood pressure.
exercise with respect to the control group (135.5¡3.3 vs. 150.4¡3.9 mmHg;
pressure after intervention (respectively 29.7 mmHg; p,0.05 and 27.4 mmHg;
p,0.05). No significant changes in both systolic and diastolic blood pressure were
Hospital admissions and adverse events.
there were more hypoglycaemia episodes in the control- than in the intervention-
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exercise advice [7] reported a significant improvement of the functional status
measured by the score on KDQoL-SF questionnaire [7]. In a very small
chronic ambulatory peritoneal dialysis patients and in hemodialysis patients [13].
in body weight or waist circumference [3]. A larger RCT [6] reported significant
body weight [5]. Dietary intervention with reduction of daily caloric intake by
BMI with respect to controls [8]. Two other dietary interventions [11,12]
plan [9].
In one study [3], systolic blood pressure was significantly reduced after resistance
p50.05). Two dietary interventions [11,12] significantly reduced mean arterial
reported by other studies [5,6,8,9,10,13].
In the study of Sigal [6] two hospitalisations not related to the aerobic exercise
program were recorded in the intervention group. In the trial of Castaneda [3],
group (7 vs. 5). In Cappy [10], two patients dropped out because of arthritic
problems. In all the other studies, adverse events or hypoglycaemia episodes were
not mentioned.
Discussion
Results from our systematic review indicate that, overall, the evidence on the
effects of energy control in diabetics with CKD, either achieved by increased
energy expenditure or by reduced energy intake, is sparse and conflicting, and is
only present for secondary outcomes. On the other hand, these interventions seem
to be relatively safe, and seem to improve general well-being.
In the general CKD population the utility of energy control is debated. Obesity
is an independent risk factor for the development and progression of CKD.
Weight loss, particularly if achieved by bariatric surgery, reduces albuminuria,
However, no solid information is available on the long-term effects on CKD
progression.
In dialysis patients reduced energy intake and low BMI are generally associated
morbid obesity was associated with improved survival and reduced cardiovascular
death. Moreover, weight loss was associated with increased cardiovascular and all-
cause death, whereas weight gain showed a trend toward improved survival. This
obesity paradox seems to be a consistent finding in many large observational trials
be stressed that all these studies are observational, and do not distinguish an
intentional weight loss from that induced by underlying inflammation or disease.
In contrast, fat loss (rather than BMI decrease) by physical exercise should be
considered as a positive endpoint. First because BMI does not seem to be an ideal
waist circumference and a higher waist/hip ratio have a stronger correlation with
all-cause and cardiovascular mortality than BMI. Second, several studies
demonstrated that a higher muscle mass exerts a protective effect regarding
high level of fitness and aerobic capacity is independently associated with
increased survival, and the obesity paradox is mainly present in patients with low
and a gain of muscle mass, as is obtained with physical exercise, should be
favourable. Nevertheless, the obesity paradox in ESKD patients has biological
plausibility and stays a point of discussion. Many explanations have been
proposed, including a more stable hemodynamic status in obese individuals,
reverse causation, survival bias, loss of lean body mass, cytokine and
neurohormonal alternations and, probably most important, the overwhelming
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proteinuria and normalizes GFR in obese patients with non-terminal CKD [14].
with an increased risk of morbidity and mortality [15,16,17]. Conversely, high
BMI exerts a protective effect on survival [18,19]. This so-called ‘‘dialysis obesity
paradox’’ was clearly outlined in a large prospective cohort study [20] where even
in hemodialysis and peritoneal dialysis patients [21], but also in other chronic
diseases like heart failure [22] and coronary heart disease [23]. However, it should
marker for visceral obesity [21]. Postorino et al. [24] have shown that increased
mortality [25,26,27,28], and that visceral fat mass is detrimental. In addition, a
cardio-respiratory fitness [29,30]. Accordingly, a weight loss of mainly fat tissue
negative effect of the malnutrition inflammation complex on traditional
unacceptably high risk for premature death, mainly because of cardiovascular
endothelial dysfunction, oxidative stress, vascular calcification and inflammation
are strongly interrelated and together play a major role in the initiation and
progression of vascular disease in CKD. The question remains if weight loss or
especially protein-wasting increases these processes and in this way augment the
cardiovascular risk. This is an interesting subject for future research.
The increasing prevalence of overweight and obesity worldwide is alarming and
lifestyle and unhealthy diet are the main causes of obesity, many efforts have
focused on controlling energy balance. Dietary interventions, educational
strategies and exercise regimens have shown to reduce weight and improve
general diabetic population identified 14 RCTs on exercise interventions. The
studies investigated aerobic exercise and progressive resistance training and
showed improved blood glucose control even without weight loss, decreased
visceral adipose tissue and decreased plasma triglycerides. No study reported
adverse events, but also none studied the effect on hard outcomes such as
RCT investigated the effect on cardiovascular outcomes of an intensive lifestyle
intervention in overweight or obese type 2 diabetes patients. Although the
intervention had a beneficial effect on weight, glycaemic control, waist
circumference and physical fitness, the rate of cardiovascular events was not
glycaemic control while exercise advice alone did not produce significant benefits.
Therefore, when implementing exercise in daily practice, the physician should
make sure the patient is compliant and is performing the prescribed exercise.
Aerobic exercise as well as a dietary program, significantly reduces BMI.
Interestingly, resistance exercise may reduce trunk fat mass without decreasing
BMI, therefore suggesting an increase in lean body mass. Data on the effect of
energy control on quality of life suggest a beneficial effect, an observation in
agreement with a recent systematic review of patients with CKD of various nature
(also including diabetes) showing a significant improvement in the health-related
There is too little evidence to draw conclusions on the effect of energy control
on renal function and CKD progression. In one trial, 24 h proteinuria was
study population consisted of a mixed group of diabetic and non-diabetic
patients, which may hamper the reliability of the conclusions. Two other trials
augmented after one year of intervention. The studies were prospective cohort
studies and included a small number of patients. A large systematic review that
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cardiovascular risks [20,31]. Patients with chronic kidney disease have an
disease. As summarized by Stenvinkel et al. [32] emerging evidence suggests that
has led to an unprecedented epidemic of type 2 diabetes [33]. Since sedentary
glycaemic control in type 2 diabetics [34]. A systematic review of studies on the
mortality or Major Adverse Cardiovascular Events [35]. A recently published large
affected [36]. There is enough evidence that exercise significantly improves
QoL after any exercise training program [37].
significantly reduced by a combination of diet and exercise regimen [8] but the
with a dietary intervention showed a significant reduction of proteinuria [11,12].
In the article of Solerte et al. [11], the mean creatinine clearance significantly
investigated the effect of weight loss on proteinuria in CKD patients came to the
same conclusion: weight loss is associated with decreased proteinuria and
diet, medication and bariatric surgery and the population studied had CKD of
mixed stages and included both diabetics and non-diabetics. Only one study of
resistance exercise intervention reported a significant reduction in systolic blood
exercise intervention significantly reduced systolic and diastolic blood pressure,
although absolute changes were small. Two dietary interventions showed a small
similar to the results of a large exercise intervention trial in a general type 2
diabetes population: systolic and diastolic blood pressure significantly reduced
other hand, another systematic review focusing on a general diabetic population
Finally, there is no evidence available on the effect of energy control on
mortality, MACEs or hospital admissions. Few studies reported these outcomes,
but none indicated association with the intervention, suggesting that promoting
not demonstrate a substantial impact of intensive lifestyle interventions on (acute)
cardiovascular events in obese type 2 DM patients although, as mentioned, such
interventions improved HbA1c and BMI as well as quality of life, physical
functioning and mobility.
No increase of hypoglycemic events was reported. This is of particular interest,
because hypoglycemia is an established risk factor associated with cardiovascular
complications such as coronary artery diseases, congestive heart failure, stroke and
compared with intensive treatment in type 2 diabetes, a retrospective analysis
showed a hazard ratio of 2.87 for all-cause mortality in patients with severe vs.
confirmed the higher risk of stroke and mortality in patients with hypoglycemia in
dietary interventions did not increase the number of hypoglycemia episodes.
Our review has some strengths and limitations. Strengths include a systematic
search of medical databases, data extraction and analysis and study quality
assessment made by two independent reviewers according to current methodo-
logical standards. However, although comprehensive search strategies focused on
a specific population (diabetic CKD patients) and intervention (any approach
targeting energy expenditure or energy intake) were implemented, publication
bias cannot be excluded. In order to maximize the number of included studies we
decided to adopt broad criteria, considering any paper including at least a
subpopulation of diabetic patients with acknowledged renal dysfunction. Yet, in
most studies diabetic (or CKD) patients often represented only a minor
subpopulation of the whole study cohort and subgroup analyses according to
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microalbuminuria [38]. There were no data provided however on the effect on the
progression of CKD. In this review [38], the interventions consisted of exercise,
pressure [3]. In the systematic review of Heiwe [37] in CKD patients, any type of
but significant reduction in mean arterial pressure [11,12]. These results are
after the intervention, but the absolute changes were again small [39]. On the
[35] showed no effect of any type of exercise on blood pressure control.
energy control might not be harmful. Similarly, the Look AHEAD trial [36] did
death [40,41,42,43,44]. In the ACCORD trial where conventional treatment was
non-severe hypoglycemia [45]. A recently published retrospective cohort study
CKD subjects [46]. In all of the studies included in this review, exercise and
CKD stage were not performed. This notably hampers the generalizability of
findings to the whole diabetic CKD population. There was a high heterogeneity in
the number of subjects enrolled, severity of diabetes (glycaemic control) and renal
impairment, presence of co-morbidities, follow-up, type and duration of
interventions (mostly exercise-based) which prevented us to perform data
pooling. Furthermore, the majority of the included studies enrolled few patients
and were powered to observe differences in surrogate rather than patient-centred
outcomes. Due to this heterogeneity of the studies and the limited data available,
it should be methodologically incorrect to perform a true meta-analysis. In
conclusion, there is lack of evidence that energy control in diabetic CKD patients
can improve hard patient centred outcomes (e.g. mortality, MACE, hospitaliza-
tions). There is however enough evidence that promoting energy expenditure or
reducing energy intake (particularly by lifestyle interventions) might be useful for
improving glycaemic control, BMI, body composition, quality of life and physical
functioning. This might translate into better long-term outcomes, but future
studies focusing on hard outcomes are needed. It is likely that the ‘dose’ of
interventions to improve energy balance may have been inadequate in many of the
studies we reviewed, with relatively small increases in energy expenditure on
exercise programmes, and relatively small decreases in calorie intake in patients
given dietary advice: if it were possible to persuade patients with diabetes and
CKD to take enough exercise, for instance, more weight loss, improved fitness,
and better long-term outcomes would be expected. Since there is also no evidence
that these programs may harm, it would be reasonable to recommend energy
control in those patients who are likely to benefits the most, like obese diabetic
CKD patients. When introducing such measures in diabetic ESKD patients, we
should provide professional advice and guidance to prevent malnutrition in this
frail population.
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